MPDL3280A: Immunotherapy Drug Shows Promise Against Range Of Cancers
Category: WELLNESS
The drug, called MPDL3280A, significantly shrank tumors in 21 percent of 140 patients with advanced melanoma, lung cancer
By Reuters, Reuters, 2013-05-15